Physician profile
Anna Jo Koch
NPI 1730889577
$1,051.75
in general payments reported to CMS, 2019-2025
13 companies · $30.32 in 2025
The $30.32 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $271 · 2024: $751 · 2025: $30.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $227.36 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $151.29 | 2024 | Otezla, Enbrel, Repatha |
| Pfizer INC. | $146.01 | 2023-2025 | |
| Abbvie INC. | $124.76 | 2023-2024 | |
| Exact Sciences Corporation | $91.55 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.39 | 2023-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $53.17 | 2023-2024 | |
| Lilly USA, LLC | $53.11 | 2024 | Zepbound, Mounjaro, Jardiance |
| Radius Health, INC. | $44.48 | 2023-2024 | Tymlos |
| Nevro Corp. | $20.95 | 2024 | Senza |
| Mylan Specialty L.P. | $19.20 | 2024 | Yupelri |
| Inspire Medical Systems, INC. | $17.82 | 2024 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.66 | 2024 | Trulance, Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Koch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.